The Rheumatologist
COVID-19 News
You are here: Home / Articles / Study Probes Whether Belimumab Can Lower Vasculitis Relapse Rate

Study Probes Whether Belimumab Can Lower Vasculitis Relapse Rate

• By Catherine Kolonko

Catherine Kolonko is a medical writer based in Oregon.

Reference

  1. Jayne D, Blockmans D, Luqmani R, et al. Efficacy and safety of belimumab and azathioprine for maintenance of remission in antineutrophil cytoplasmic antibody-associated vasculitis: A randomized controlled study. Arthritis Rheumatology. 2019 Jun;71(6):952–963.

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »